Deanna Kelly, PharmD, BCPP
University of Maryland
Deanna L. Kelly, Pharm.D., BCPP is Professor of Psychiatry at University of Maryland Baltimore School of Medicine and Affiliate Professor in the School of Pharmacy. She is currently Director and Chief of the Treatment Research Program at the Maryland Psychiatric Research Center (MPRC). Dr. Kelly received her Bachelor of Science and Doctorate in Pharmacy at Duquesne University in Pittsburgh, PA. She completed residency training in psychiatric pharmacy practice at the University of Maryland in 1997 and became board certified in psychiatric pharmacy practice in 1998.
Dr. Kelly has led and been involved in numerous clinical trials in schizophrenia and has been active in psychopharmacology research for the past 20 years. She has been continuously funded by NIMH, NIDA, and private foundations such as the Stanley Medical Research Institute and the Maryland Innovation Initiative for over 17 years.
Dr. Kelly has coauthored and authored 16 books and book chapters, published 169 peer-reviewed articles, presented over 140 posters and has given over 135 invited lectures. She has coauthored three editions of the book entitled “Pharmacologic Treatment of Schizophrenia.” She also authors the Schizophrenia chapter for “Pharmacotherapy, Principles and Practice.” Among many other activities she reviews for over 30 psychiatry journals and serves as a founding and current Associate Editor for Clinical Schizophrenia and Related Psychoses. Dr Kelly chairs the Junior Faculty Mentoring Committee at MPRC, and serves as Vice Chair of the State of Maryland Department of Health and Mental Hygiene Institutional Review Board.
She is the recipient of the 2017 Maltz Prize for Innovative and Promising Schizophrenia Research from the Brain and Behavior Research Foundation.